"I am proud to be involved with the first conference geared specifically for the cardiovascular med-tech R&D audience. The time is right for such a meeting, as our industry has never been more complex—as such, it is critical for med-tech engineers to stay ahead of the curve in their thinking about issues impacting next-gen device design and development. MedTech Cardio is assembling a super group of key industry experts and clinical opinion leaders to guide this discussion in October, in what is sure to be a notable event." — Deborah Kilpatrick, Ph.D, Senior VP, CardioDx Inc.
"MedTech Cardio 2012 provides me the opportunity to present to the medical device community what may be disruptive technologies and to gauge the current status of the community's knowledge and perspective concerning engineered tissues for cardiovascular repair." — Prof. Robert Tranquillo, Head of Biomedical Engineering Department, University of Minnesota
"The MedTechCardio Conference will provide a comprehensive update of the cardiovascular device industry and an excellent overview of the latest approaches to improving patient outcomes using innovative scientific and technological approaches. Ariste Medical's latest advance in transforming ePTFE to a drug delivery device should have a significant impact on reduction of adverse events and improve patient morbidity and mortality. This new technology has broad impact in the cardiovascular field that continues to combat failure of small stent grafts and other implants due to scar tissue formation, infection or thrombosis." — Lisa K. Jennings, Ph.D, Founder/CSO, Ariste Medical, Inc. and Professor, University of Tennessee Health Science Center